NANTAHALA CAPITAL MANAGEMENT, LLC – Acer Therapeutics Inc. Transaction History
NANTAHALA CAPITAL MANAGEMENT, LLC portfolio value:
$968,000
portfolio value
NANTAHALA CAPITAL MANAGEMENT, LLC quarter portfolio value change:
+10.32%
quarter
Acer Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.00% | -44.47K shares | 34K | $1.39 | 696.53K |
| Q2 2022 | share | Decrease | -4.73% | -36.81K shares | -1.32M | $1.26 | 741.01K |
| Q1 2022 | share | Decrease | -13.70% | -123.47K shares | 201K | $2.9 | 777.82K |
| Q4 2021 | share | Decrease | -1.41% | -12.90K shares | -285K | $2.36 | 901.29K |
| Q3 2021 | share | Decrease | -2.20% | -20.55K shares | -333K | $2.56 | 914.19K |
| Q2 2021 | share | 0.00% | 0 shares | -234K | $2.86 | 934.75K | |
| Q1 2021 | share | Decrease | -5.56% | -55K shares | 314K | $3.11 | 934.75K |
| Q4 2020 | share | Decrease | -0.09% | -900 shares | -260K | $2.62 | 989.75K |
| Q3 2020 | share | 0.00% | 0 shares | -545K | $2.88 | 990.65K | |
| Q2 2020 | share | 0.00% | 0 shares | 1.42M | $3.43 | 990.65K | |
| Q1 2020 | share | 0.00% | 0 shares | -2.00M | $1.99 | 990.65K | |
| Q4 2019 | share | 0.00% | 0 shares | 813K | $4.01 | 990.65K | |
| Q3 2019 | share | 0.00% | 0 shares | -704K | $3.19 | 990.65K | |
| Q2 2019 | share | Increase | +12.01% | 106.2K shares | -17.62M | $3.9 | 990.65K |
| Q1 2019 | share | Decrease | -2.10% | -19K shares | 3.31M | $24.3 | 884.45K |
| Q4 2018 | share | Increase | +30.67% | 212.06K shares | -3.14M | $20.12 | 903.45K |
| Q3 2018 | share | Increase | +176.28% | 441.13K shares | 15.91M | $30.84 | 691.38K |
| Q2 2018 | share | 0.00% | 0 shares | 583K | $21.6 | 250.25K | |
| Q1 2018 | share | Increase | 0.00% | 250.25K shares | 4.82M | $19.27 | 250.25K |